HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

942.615

+1.3410.14%

Number of Gainers:6

Number of Losers:10

Number of Flat:1

PE:- -

High:948.140

Open:941.072

Low:931.273

Close:941.274

Volume:467.94M

Turnover:3.97B

Market Cap:638.59B

Float Cap:527.81B

Loading ...

Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact

CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold

CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge

Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

MT Newswires Live

CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion

CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million

THOMSON REUTERS

CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026

THOMSON REUTERS

Market Opens Higher Across All Three Major Indices, Led by Precious Metals and Pharmaceuticals

Sinopharm to Sell 51% Stake in Guorui Pharmaceutical for 406 Million Yuan

MT Newswires Live

Hong Kong Stock Market Update: SBP GROUP Jumps Over 6% After Results, H1 Revenue Hits Record 19.44 Billion Yuan, Gaining Endorsements From Top Global Pharmaceutical Firms

Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost

US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%

GENFLEET-B Advances Two First-in-Class Pancreatic Cancer Combination Therapies into Phase II Trials

China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up

Iceland's Alvotech H1 Revenue Falls 31% on Manufacturing Program

Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback

Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million

Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million

Kintor Pharmaceutical H1 Revenue RMB 52 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1515/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":942.61523,"timestamp":1787299686774,"preClose":941.2742,"halted":0,"volume":467937535,"delay":0,"changeRate":0.001425,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":1.341064,"latestTime":"08-21 16:00:00","open":941.0721,"high":948.1404,"low":931.27325,"amount":3968572485,"amplitude":0.017919,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":1.422618,"peRate":17.199147,"turnoverRate":0.006194,"increases":6,"decrements":10,"flats":1,"marketCap":638593959040,"floatMarketCap":527805996800},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":948.1404,"amplitude":0.017919,"preClose":941.2742,"low":931.27325,"pbRate":"1.422618","latestPrice":942.61523,"volume":467937535,"delay":0,"open":941.0721,"prevYearClose":1190.107,"prevWeekClose":912.416,"prevMonthClose":925.972,"prevQuarterClose":802.777,"fiveDayClose":912.416,"twentyDayClose":904.53,"sixtyDayClose":944.634,"secType":"PLATE","market":"HK","turnoverRate":0.006194,"peRate":17.199147,"marketCap":638593959040,"floatMarketCap":527805996800,"timestamp":1787299686774,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":6,"down":10,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660926405","title":"Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2660926405","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660926405?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:54","pubTimestamp":1787205278,"startTime":"0","endTime":"0","summary":"Norway's Vistin Pharma Q2 revenue falls on currency impactOverviewNorway pharmaceutical maker's Q2 revenue fell yr/yr due to stronger NOK despite 8% sales volume growthQ2 EBITDA and net profit decline","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H068:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE00B543WZ88.USD","01093","LU0501845795.SGD","LU1226287792.SGD","SG9999004220.SGD","HK0000165453.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU1328277881.USD","IE0008368742.USD","BK1191","LU0315179316.USD","LU1226287529.USD","LU1152091168.USD","LU0326950275.SGD","LU0072913022.USD","LU1813983027.USD","LU1226288170.HKD","LU0140636845.USD","IE00B5MMRT66.SGD","KURE","LU0067412154.USD","LU0314109678.HKD","LU1152091754.HKD","LU1008478684.HKD","IE00BZ08YT58.USD","BK1515","IE00B031HY20.USD","IE0008369823.USD","LU1226288253.USD","LU1807302812.USD","LU1960683339.HKD","BK1521","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189336205","title":"CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold","url":"https://stock-news.laohu8.com/highlight/detail?id=1189336205","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189336205?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:40","pubTimestamp":1787204412,"startTime":"0","endTime":"0","summary":"Shares of CSPC PHARMA (01093) climbed more than 12% following its interim results announcement, trading up 11.97% at HK$9.725 with turnover reaching HK$3.057 billion as of press time.On August 20 at...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287529.USD","LU0315179316.USD","LU0314109678.HKD","LU1951186391.HKD","LU1807302812.USD","LU1813983027.USD","LU1993786604.SGD","IE0008368742.USD","BK1521","LU0326950275.SGD","IE00B543WZ88.USD","LU1226287792.SGD","LU1226288253.USD","LU0501845795.SGD","LU1960683339.HKD","KURE","BK1515","LU0067412154.USD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK4585","LU0072913022.USD","LU0880133367.SGD","IE0008369823.USD","LU1152091754.HKD","BK4588","IE00B5MMRT66.SGD","LU1328277881.USD","IE00BZ08YR35.GBP","LU1226288170.HKD","VXUS","LU1152091168.USD","LU1226287875.USD","LU0140636845.USD","LU1008478684.HKD","BK1191","IE00B031HY20.USD","LU2039709279.SGD","SG9999004220.SGD","01093","HK0000165453.HKD","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403439","title":"CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403439","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403439?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:19","pubTimestamp":1787203167,"startTime":"0","endTime":"0","summary":"BUZZ-CSPC Pharmaceutical hits 6-month high on profit, dividend surge** Shares of CSPC Pharmaceutical Group1093.HKjump 17.1% to HK$10.17, their highest level since February 25** Stock on track for its biggest one-day pct gain since June 2012** Second-biggest percentage gainer on the benchmark Hang Seng Index.HSI, which gains 1.1%** Chinese pharmaceutical maker saidH1 profit attributablejumped 139% y/y with total revenue up 40% y/y driven by finished drugs growth** Co declares an interim dividend of HK$0.18 per share, up 28.6% from HK$0.14 each a year ago** YTD, stock up 16.9%, Hang Seng Biotech Index.HSBIOup 15.9%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H05B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287529.USD","LU0315179316.USD","LU0314109678.HKD","LU1951186391.HKD","LU1807302812.USD","LU1813983027.USD","LU1993786604.SGD","IE0008368742.USD","BK1521","LU0326950275.SGD","IE00B543WZ88.USD","LU1226287792.SGD","LU1226288253.USD","LU0501845795.SGD","LU1960683339.HKD","KURE","BK1515","LU0067412154.USD","IE00BZ08YT58.USD","LU0072913022.USD","LU0880133367.SGD","IE0008369823.USD","LU1152091754.HKD","IE00B5MMRT66.SGD","LU1328277881.USD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU1152091168.USD","LU1226287875.USD","LU0140636845.USD","LU1008478684.HKD","BK1191","IE00B031HY20.USD","LU2039709279.SGD","SG9999004220.SGD","01093","HK0000165453.HKD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403108","title":"Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403108","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403108?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:18","pubTimestamp":1787203114,"startTime":"0","endTime":"0","summary":"Finland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cutsOverviewFinland medicine performance-enhancer's Q2 revenue grew 16% yr/yr, adjusted EPS loss narrowedCompany's Q2 EBITDA loss narrowed as","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H05H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","HK0000165453.HKD","BK1589","01177","BK1515","ONT.UK","IE00BZ08YT58.USD","BK5062","BK1191","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403998","title":"CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403998?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:09","pubTimestamp":1787202587,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  reported an over 139% jump in attributable profit for the first half of 2026 to 6.09 billion yuan from 2.55 billion yuan a year earlier, according to a Thursday Hong Kong bourse filing.Earnings per share for the six months ended June 30 climbed to 0.5336 yuan from 0.2229 yuan in the prior-year period.Revenue of the pharma company jumped 40.1% year on year to 18.6 billion yuan from 13.3 billion yuan.The company declared an interim dividend of HK$0.18 per share, payable on Nov. 10 to shareholders of record on Oct. 26.Shares of the company jumped nearly 14% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0880133367.SGD","IE00B5MMRT66.SGD","IE00B031HY20.USD","BK1515","IE00BZ08YT58.USD","LU1152091168.USD","LU1226287875.USD","FCA","LU1328277881.USD","KURE","LU0314109678.HKD","LU1226288253.USD","LU1807302812.USD","LU0315179316.USD","LU0326950275.SGD","LU0140636845.USD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","HK0000165453.HKD","LU1960683339.HKD","IE0008368742.USD","LU1226288170.HKD","01093","LU1993786604.SGD","BK1191","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1152091754.HKD","LU0072913022.USD","LU0501845795.SGD","IE0008369823.USD","BK1521","LU0067412154.USD","LU1226287529.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1813983027.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660906408","title":"CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660906408","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660906408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:19","pubTimestamp":1787199569,"startTime":"0","endTime":"0","summary":"CSPC Pharma FY26 H1 profit attributable to shareholders more than doubled to RMB 6.09 billion; revenue rises 40.1% to RMB 18.59 billionCSPC Pharmaceutical posted first-half revenue of RMB 18.59 billio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6XHzX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","LU1152091754.HKD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1813983027.USD","LU1993786604.SGD","LU0315179316.USD","HK0000165453.HKD","BK1191","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","IE00BZ08YT58.USD","BK1515","LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B5MMRT66.SGD","01093","LU0067412154.USD","IE0008368742.USD","IE00B543WZ88.USD","BK1521","LU0140636845.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660408970","title":"CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660408970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660408970?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226288170.HKD","LU1008478684.HKD","IE00BZ08YS42.EUR","KURE","LU1960683339.HKD","LU1993786604.SGD","LU2039709279.SGD","IE0008369823.USD","BK1515","LU0067412154.USD","LU0501845795.SGD","LU1807302812.USD","LU1951186391.HKD","IE00B031HY20.USD","LU1152091754.HKD","LU1226287875.USD","LU0880133367.SGD","BK1521","LU1813983027.USD","LU0326950275.SGD","LU0140636845.USD","LU0314109678.HKD","IE0008368742.USD","LU0072913022.USD","LU1226287792.SGD","LU1226288253.USD","LU1328277881.USD","SG9999004220.SGD","HK0000165453.HKD","01093","BK1191","IE00BZ08YR35.GBP","LU0315179316.USD","IE00B543WZ88.USD","LU1152091168.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660140897","title":"CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660140897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660140897?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1960683339.HKD","SG9999004220.SGD","LU0314109678.HKD","BK1191","LU1226287875.USD","LU1226288170.HKD","LU1951186391.HKD","LU0880133367.SGD","LU1226287792.SGD","LU0140636845.USD","BK1515","IE00BZ08YS42.EUR","HK0000165453.HKD","IE0008368742.USD","IE00B031HY20.USD","LU1152091754.HKD","KURE","LU0315179316.USD","IE00BZ08YT58.USD","BK1521","LU1328277881.USD","01093","LU1807302812.USD","LU2039709279.SGD","LU1226288253.USD","LU0326950275.SGD","IE0008369823.USD","IE00B543WZ88.USD","LU0067412154.USD","LU1152091168.USD","LU0501845795.SGD","LU1813983027.USD","LU1008478684.HKD","LU0072913022.USD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU1226287529.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178179537","title":"Market Opens Higher Across All Three Major Indices, Led by Precious Metals and Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1178179537","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178179537?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:46","pubTimestamp":1787190382,"startTime":"0","endTime":"0","summary":"Trading data shows that on August 20, the Shanghai Composite Index opened up 0.33% at 3907.21 points, the Shenzhen Component Index opened up 1.03% at 14032.97 points, the ChiNext Index opened up...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","02827","DBP","83130","BK1161","BK1515","399300","YSAG","09939","BK1574","BK1147","83188","07233","03130","03188","02846","159938","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660147248","title":"Sinopharm to Sell 51% Stake in Guorui Pharmaceutical for 406 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660147248","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660147248?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:46","pubTimestamp":1787190375,"startTime":"0","endTime":"0","summary":"Sinopharm  agreed to sell a combined 51% stake in China National Medicines Guorui Pharmaceutical for 406.4 million yuan, according to a Wednesday Hong Kong bourse filing.Sinopharm will sell a 30.13% direct stake for 240.1 million yuan, while its subsidiary Sinopharm  will dispose of a 12.06% stake for 96.1 million yuan.China National Pharmaceutical will sell the remaining 8.81% for 70.2 million yuan.Upon completion, Guorui Pharmaceutical will cease to be consolidated by Sinopharm, with Sinopharm  retaining a 49% stake and Shanghai Shyndec Pharmaceutical holding 51%.Sinopharm expects to record a preliminary gain of about 45 million yuan from the disposal, with proceeds to be used to replenish working capital.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1500","01099","FCA","BK1515","BK1197","LU1115378108.SGD","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158543575","title":"Hong Kong Stock Market Update: SBP GROUP Jumps Over 6% After Results, H1 Revenue Hits Record 19.44 Billion Yuan, Gaining Endorsements From Top Global Pharmaceutical Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1158543575","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158543575?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:34","pubTimestamp":1787189667,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) surged more than 6% at the market open following the release of its interim results, with shares climbing 6.05% to HK$5.08 at the time of writing, and transaction volume reaching...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","VXUS","IE00BZ08YR35.GBP","BK1589","BK4585","IE00BZ08YS42.EUR","KCAI","BK4588","IE00BZ08YT58.USD","01177","BK1515","BK1521","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129240025","title":"Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=1129240025","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129240025?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:34","pubTimestamp":1787189660,"startTime":"0","endTime":"0","summary":"CansinoBio (06185) opened 15% higher in Hong Kong trading, with shares last up 15% at HK$26.84, recording a turnover of HK$3.88 million. The surge comes after Moderna and Merck announced on the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","VXUS","06185","BK4585","KCAI","BK1574","BK4588","159646","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146381026","title":"US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146381026","media":"Stock News","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146381026?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:10","pubTimestamp":1787188237,"startTime":"0","endTime":"0","summary":"Market Open Briefing1. US Treasury intervention steadies markets; Moderna surges 176%US stocks snapped a three-session losing streak after the Treasury Department moved to address bond market...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK1161","07233","159982","83130","BK1515","BK4534","BK4585","09939","BK4139","BK1574","83188","BK4532","WDNA","BK4533","02827","BK4588","399300","BK4551","BK1147","GNOM","03130","03188","MRNX","MRNA","MRNY","BK4568","IDNA","LGHT","BK4501","02846","159938","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193023804","title":"GENFLEET-B Advances Two First-in-Class Pancreatic Cancer Combination Therapies into Phase II Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1193023804","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193023804?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:16","pubTimestamp":1787184978,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has announced the initiation of a three-arm, parallel-controlled Phase II clinical study evaluating GFH375, an oral KRAS G12D ON/OFF inhibitor. The trial will assess two novel...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161","BK1515","09939","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479671","title":"China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479671","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479671?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:17","pubTimestamp":1787181459,"startTime":"0","endTime":"0","summary":"China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-upOverviewChina oncology drug developer's H1 revenue rose 29% yr/yr on higher product salesNet loss widened as operating expenses and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G15G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","IE00BZ08YR35.GBP","BK1574","06990","06855","LU2148510915.USD","IE00BZ08YT58.USD","LU1979443071.USD","BK1589","LU1064131003.USD","BK1521","BK1191","LU1934453819.USD","01177","BK0060","LU1064130708.USD","BK1515","BK0239","002422","HK0000165453.HKD","BK1161","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660475137","title":"Iceland's Alvotech H1 Revenue Falls 31% on Manufacturing Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2660475137","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660475137?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:14","pubTimestamp":1787174061,"startTime":"0","endTime":"0","summary":"Iceland's Alvotech H1 revenue falls 31% on manufacturing programOverviewIceland biosimilar medicines developer's H1 revenue fell 31% yr/yr due to manufacturing programAdjusted EBITDA declined as manuf","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G129:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1515","HK0000306701.USD","00656","ALVO","BK1191","BK4139","01177","HK0000320264.USD","BK1589","HK0000320223.HKD","HK0000306685.HKD","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1521","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170810384","title":"Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1170810384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170810384?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150452,"startTime":"0","endTime":"0","summary":"Here are the key evening market developments investors need to know. NDRC Advances 'Six Networks' Infrastructure Plan On August 19, the National Development and Reform Commission (NDRC) held a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03130","BK1147","02846","159938","159982","399300","82846","BK1574","09939","159646","83130","07233","03188","BK1515","02827","83188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178952366","title":"Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1178952366","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178952366?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150416,"startTime":"0","endTime":"0","summary":"Kintor Pharma-B (09939) has unveiled its interim financial results for the period ending June 30, 2026, showcasing a notable surge in revenue from RMB 6 million in the prior-year period to RMB 52...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660242429","title":"Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660242429","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660242429?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:33","pubTimestamp":1787149999,"startTime":"0","endTime":"0","summary":"Kintor net loss narrows 9% to RMB 75.8 million in 1H FY26; revenue rises to RMB 52 millionKintor posted revenue of RMB 52 million, up 766.7% year over year, driven by global sales of its KOSHIN cosmet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL7xt97N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429211","title":"Kintor Pharmaceutical H1 Revenue RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429211?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:32","pubTimestamp":1787149978,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXXDMDQT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09939","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":4,"totalSize":211,"code":"91000000","status":"200"}]}}